Plain-English translation of NCT07392190 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing a new medication called to see if it helps adults with obesity or overweight lose weight more effectively. The medication is given as a weekly injection and is being studied in people who are already taking another type of weight loss or diabetes medication. Researchers want to understand whether this new treatment works better than placebo (a dummy injection with no active drug) and whether it's safe.
Many people struggle to lose weight even with current medications available, and their weight loss can stop or plateau over time. This trial is exploring whether this medication could offer a more effective option for people whose weight hasn't improved enough with their existing treatment.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll be randomly assigned to receive either the new medication or a placebo injection once per week for about 80 weeks (roughly 18 months). You'll continue taking your current weight loss or diabetes medication as normal. Throughout the study, you'll have regular visits where researchers will check your weight, measure your health, and ask about any side effects you're experiencing.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
United States